Journal remit · ISSN 2372-6601
Aims & Scope
The Journal of Hematology and Oncology Research publishes work that advances understanding of blood disorders and cancer across basic, translational, clinical and diagnostic research.
Submissions should make a clear contribution to disease biology, classification, diagnosis, treatment or patient care within hematology or oncology.
- BasicMechanisms, pathways and disease models
- TranslationalFindings that connect laboratory and clinical questions
- ClinicalPatient-focused investigation and therapeutic evidence
- DiagnosticBiomarkers, classification and validated methods
Is this manuscript a fit?
A useful submission should satisfy all three checks.
Relevant subject
The central research question concerns hematology, oncology or a direct interface between them.
Meaningful contribution
The work adds interpretable evidence about mechanism, diagnosis, prognosis, treatment or outcomes.
Appropriate evidence
The study design, analysis and reporting support the conclusions and the selected article type.
Core domains
Research areas considered by JHOR
The journal considers work across malignant and non-malignant hematology and across solid and hematologic cancers, provided the manuscript has a defined scientific or clinical contribution.
Molecular oncology
Cancer genomics and epigenetics, malignant transformation, signaling, tumor microenvironment, stem-cell biology, metastasis and invasion.
Hematological pathophysiology
Hematopoiesis, lineage commitment, leukemias and lymphomas, anemias, coagulopathies, platelet or leukocyte dysfunction and the marrow microenvironment.
Cancer immunology
Tumor–immune interaction, immune evasion, checkpoint regulation, antigen recognition, T-cell dysfunction and immunosuppressive mechanisms.
Biomarkers and molecular diagnostics
Biomarker discovery and validation, molecular classification, prognosis, liquid biopsy, genetic or proteomic profiling and diagnostic targets.
- Pharmacogenetics
- Drug resistance
- Disease models
- Molecular cytogenetics
- Tumor metabolism
- Angiogenesis
- Hereditary cancer genetics
- Single-cell studies
- Computational and omics analysis
Questions and outcomes
Research we consider
JHOR welcomes laboratory, translational and clinical approaches when the study is clearly connected to a hematologic or oncologic question.
Mechanisms and pathobiology
Work explaining cellular, molecular, genetic, epigenetic or immune processes in disease.
Diagnosis and classification
Studies that evaluate markers, molecular signatures, diagnostic tools or disease subtypes.
Prognosis and risk
Evidence on disease course, recurrence, stratification or clinically meaningful outcomes.
Therapeutics and resistance
Preclinical or clinical investigation of interventions, response and resistance mechanisms.
Methods and models
Validated experimental, computational or model systems that answer a field-relevant question.
Clinical observations
Patient-based evidence with a clear diagnostic, therapeutic, mechanistic or practice implication.
Scope boundaries
What strengthens—or weakens—fit
These examples help authors assess relevance before submission. They do not predetermine the editorial outcome of an individual manuscript.
Suitable
- A defined hematology or oncology question is central to the manuscript.
- The findings add biological, diagnostic, translational or clinical insight.
- Methods and reporting permit readers to evaluate the conclusions.
Conditional fit
- Computational, AI or omics work needs clear disease relevance and appropriate validation.
- Methods or model papers should demonstrate their value to a hematology or oncology question.
- Case reports or series should offer a rare presentation, therapeutic response or distinct biological insight.
Check before submitting
- Work in which the connection to hematology or oncology is indirect or not yet explained.
- Technical descriptions that need a clearer scientific or clinical question in the field.
- Clinical observations that need a clearer diagnostic, mechanistic or treatment contribution.
Publication formats
Article types currently considered
The current submission system and JHOR manuscript record support the formats listed here. Historical archive labels do not define current eligibility.
- Research Articles
- Review Articles
- Case Reports
- Short Communications
- Mini-reviews
- Letters
Audience
JHOR is intended for researchers, physician-scientists, clinicians and other specialists working across hematology, oncology, pathology, molecular medicine and related translational disciplines.
Ready to prepare your submission?
Check the current manuscript requirements before submitting. Scope fit and scientific quality are assessed independently of payment or commercial considerations.